9 results on '"Schiavoni, V."'
Search Results
2. Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines.
- Author
-
Schiavoni V, Emanuelli M, Campagna R, Cecati M, Sartini D, Milanese G, Galosi AB, Pozzi V, and Salvolini E
- Subjects
- Humans, Cell Line, Tumor, Cell Movement, Cell Proliferation, Cell Survival drug effects, Cell Survival genetics, Gene Expression Regulation, Neoplastic, Gene Silencing, Aryldialkylphosphatase genetics, Aryldialkylphosphatase metabolism, Carcinoma, Renal Cell genetics, Carcinoma, Renal Cell pathology, Carcinoma, Renal Cell metabolism, Kidney Neoplasms genetics, Kidney Neoplasms pathology, Kidney Neoplasms metabolism, RNA, Small Interfering genetics, RNA, Small Interfering metabolism
- Abstract
Clear cell renal cell carcinoma (ccRCC) represents the most common subtype of renal tumor. Despite recent advances in identifying novel target molecules, the prognosis of patients with ccRCC continues to be poor, mainly due to the lack of sensitivity to chemo- and radiotherapy and because of one-third of renal cell carcinoma patients displays metastatic disease at diagnosis. Thus, identifying new molecules for early detection and for developing effective targeted therapies is mandatory. In this work, we focused on paraoxonase-2 (PON2), an intracellular membrane-bound enzyme ubiquitously expressed in human tissues, whose upregulation has been reported in a variety of malignancies, thus suggesting its possible role in cancer cell survival and proliferation. To investigate PON2 involvement in tumor cell metabolism, human ccRCC cell lines were transfected with plasmid vectors coding short harpin RNAs targeting PON2 transcript and the impact of PON2 silencing on cell viability, migration, and response to chemotherapeutic treatment was then explored. Our results showed that PON2 downregulation was able to trigger a decrease in proliferation and migration of ccRCC cells, as well as an enhancement of cell sensitivity to chemotherapy. Thus, taken together, data reported in this study suggest that the enzyme may represent an interesting therapeutic target for ccRCC., (© 2024 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
3. Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential.
- Author
-
Schiavoni V, Emanuelli M, Sartini D, Salvolini E, Pozzi V, and Campagna R
- Abstract
Oral Squamous Cell Carcinoma (OSCC) is the most common cancer arising from squamous epithelium in the oral cavity and is characterized by high aggressiveness and metastatic potential, which together with a late diagnosis results in a 5-year survival rate of only 50% of patients. The therapeutic options for OSCC management are limited and largely influenced by the cancer stage. While radical surgery can be curative in early stage of disease, most cases require adjuvant therapies, including chemotherapy and radiotherapy which, however, often achieve poor curative rates and are associated with important negative effects. Therefore, there is an urgent need to discover new alternative treatment strategies to improve patients' outcomes. Several medicinal herbs are being studied for their preventive or therapeutic effect in several diseases, including cancer. In particular, the Indian spice curcumin, largely used in oriental countries, has been studied as a chemopreventive or adjuvant agent for different malignancies. Indeed, curcumin is characterized by important biological properties, including antioxidant, anti-inflammatory, and anticancer effects, which could also be exploited in OSCC. However, due to its limited bioavailability and poor aqueous solubility, this review is focused on studies designing new synthetic analogues and developing novel types of curcumin delivery systems to improve its pharmacokinetic and biological properties. Thus, this review analyses the potential therapeutic role of curcumin in OSCC by providing an overview of current in vitro and in vivo studies demonstrating the beneficial effects of curcumin and its analogues in OSCC., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
4. In Vitro Study of the Proliferation of MG63 Cells Cultured on Five Different Titanium Surfaces.
- Author
-
Campagna R, Schiavoni V, Marchetti E, Salvolini E, Frontini A, Sampalmieri F, Bambini F, and Meme' L
- Abstract
The use of dental implants for prosthetic rehabilitation in dentistry is based on the concept of osteointegration. This concept enables the clinical stability of the implants and a total absence of inflammatory tissue between the implant surface and the bone tissue. For this reason, it is essential to understand the role of the titanium surface in promoting and maintaining or not maintaining contact between the bone matrix and the surface of the titanium implant., Materials and Methods: Five types of titanium discs placed in contact with osteoblast cultures of osteosarcomas were studied. The materials had different roughness. Scanning electron microscopy (SEM) photos were taken before the in vitro culture to analyze the surfaces, and at the end of the culturing time, the different gene expressions of a broad pattern of proteins were evaluated to analyze the osteoblast response, as indicated in the scientific literature., Results: It was demonstrated that the responses of the osteoblasts were different in the five cultures in contact with the five titanium discs with different surfaces; in particular, the response in the production of some proteins was statistically significant., Discussion: The key role of titanium surfaces underlines how it is still possible to carry out increasingly accurate and targeted studies in the search for new surfaces capable of stimulating a better osteoblastic response and the long-term maintenance of osteointegration.
- Published
- 2024
- Full Text
- View/download PDF
5. Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy.
- Author
-
Cirilli N, Schiavoni V, Tagliabracci V, Gesuita R, Tiano L, Fabrizzi B, D'Antuono A, Peruzzi A, Cedraro N, Carle F, Moretti M, Ferrante L, Vignaroli C, Biavasco F, and Mangiaterra G
- Abstract
Background: Lung infections antibiotic treatment in Cystic Fibrosis patients (pwCF) is often complicated by bacterial persisters, including the so-called Viable but Non Culturable (VBNC) forms, live cells undetected by the routine cultural microbiological methods. This study investigated the occurrence of VBNC cells of five CF bacterial pathogens in 94 pwCF over one year and the possible associations with the patients' clinical features., Methods: Sputum samples, recovered at routine visits and during exacerbation episodes, were analyzed for the presence of the five pathogens by both routine culture-based assays and species-specific qPCR. VBNC cells were estimated as the difference between molecular and cultural counts and their presence was matched with the clinical data in particular the therapeutic regimens., Results: All but ten pwCF showed the presence of VBNC cells at least once during the study. Pseudomonas aeruginosa and methicillin-susceptible Staphylococcus aureus were the species most frequently found in the VBNC state. Only the former showed a significant association between chronic infection and VBNC cells presence; VBNC-MSSA positive patients significantly increased overtime. The presence of non culturable bacteria was generally concurrent with poor lung functionality and more frequent pulmonary exacerbations. No significant association with modulator treatment was evidenced., Conclusions: The obtained data demonstrated the overwhelming occurrence of bacterial VBNC cells in CF lung infections, warranting a constant monitoring of pwCF and underlining the need of implementing the routine culture-based assays with culture-independent techniques. This is pivotal to understand the CF bacterial population dynamics and to efficiently contrast the lung infection progression and worsening., Competing Interests: Declaration of competing interest The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript., (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes.
- Author
-
Campagna R, Serritelli EN, Salvolini E, Schiavoni V, Cecati M, Sartini D, Pozzi V, and Emanuelli M
- Subjects
- Humans, Aryldialkylphosphatase genetics, Aryldialkylphosphatase metabolism, Phenotype, Reactive Oxygen Species metabolism, Endothelial Cells metabolism, Neoplasms
- Abstract
Paraoxonase-2 (PON2) is a ubiquitously expressed intracellular protein that is localized in the perinuclear region, the endoplasmic reticulum (ER), and mitochondria, and is also associated with the plasma membrane. PON2 functions as an antioxidant enzyme by reducing the levels of reactive oxygen species (ROS) in the mitochondria and ER through different mechanisms, thus having an anti-apoptotic effect and preventing the formation of atherosclerotic lesions. While the antiatherogenic role played by this enzyme has been extensively explored within endothelial cells in association with vascular disorders, in the last decade, great efforts have been made to clarify its potential involvement in both blood and solid tumors, where PON2 was reported to be overexpressed. This review aims to deeply and carefully examine the contribution of this enzyme to different aspects of tumor cells by promoting the initiation, progression, and spread of neoplasms.
- Published
- 2024
- Full Text
- View/download PDF
7. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.
- Author
-
Schiavoni V, Campagna R, Pozzi V, Cecati M, Milanese G, Sartini D, Salvolini E, Galosi AB, and Emanuelli M
- Abstract
Renal cell carcinoma (RCC) belongs to a heterogenous cancer group arising from renal tubular epithelial cells. Among RCC subtypes, clear cell renal cell carcinoma (ccRCC) is the most common variant, characterized by high aggressiveness, invasiveness and metastatic potential, features that lead to poor prognosis and high mortality rate. In addition, diagnosis of kidney cancer is incidental in the majority of cases, and this results in a late diagnosis, when the stage of the disease is advanced and the tumor has already metastasized. Furthermore, ccRCC treatment is complicated by its strong resistance to chemo- and radiotherapy. Therefore, there is active ongoing research focused on identifying novel biomarkers which could be useful for assessing a better prognosis, as well as new molecules which could be used for targeted therapy. In this light, several novel targeted therapies have been shown to be effective in prolonging the overall survival of ccRCC patients. Thus, the aim of this review is to analyze the actual state-of-the-art on ccRCC diagnosis, prognosis and therapeutic options, while also reporting the recent advances in novel biomarker discoveries, which could be exploited for a better prognosis or for targeted therapy.
- Published
- 2023
- Full Text
- View/download PDF
8. MQT-TZ: Secure MQTT Broker for Biomedical Signal Processing on the Edge.
- Author
-
Segarra C, Delgado-Gonzalo R, and Schiavoni V
- Subjects
- Communication, Computer Security, Electrocardiography, Humans, Privacy, Signal Processing, Computer-Assisted
- Abstract
Physical health records belong to healthcare providers, but the information contained within belongs to each patient. In an increasing manner, more health-related data is being acquired by wearables and other IoT devices following the ever-increasing trend of the Quantified Self. Even though data protection regulations (e.g., GDPR) encourage the usage of privacy-preserving processing techniques, most of the current IoT infrastructure was not originally conceived for such purposes. One of the most used communication protocols, MQTT, is a lightweight publish-subscribe protocol commonly used in the Edge and IoT applications. In MQTT, the broker must process data on clear text, hence exposing a large attack surface for a malicious agent to steal/tamper with this health-related data. In this paper, we introduce MQT-TZ, a secure MQTT broker leveraging Arm TRUSTZONE, a popular Trusted Execution Environment (TEE). We define a mutual TLS-based handshake and a two-layer encryption for end-to-end security using the TEE as a trusted proxy. We provide quantitative evaluation of our open-source PoC on streaming ECGs in real time and highlight the trade-offs.
- Published
- 2020
- Full Text
- View/download PDF
9. Secure Stream Processing for Medical Data.
- Author
-
Segarra C, Muntane E, Lemay M, Schiavoni V, and Delgado-Gonzalo R
- Subjects
- Delivery of Health Care, Electrocardiography, Humans, Male, Privacy, Software, Computer Security, Electronic Data Processing, Wearable Electronic Devices
- Abstract
Medical data belongs to whom it produces it. In an increasing manner, this data is usually processed in unauthorized third-party clouds that should never have the opportunity to access it. Moreover, recent data protection regulations (e.g., GDPR) pave the way towards the development of privacy-preserving processing techniques. In this paper, we present a proof of concept of a streaming IoT architecture that securely processes cardiac data in the cloud combining trusted hardware and Spark. The additional security guarantees come with no changes to the application's code in the server. We tested the system with a database containing ECGs from wearable devices comprised of 8 healthy males performing a standardized range of in-lab physical activities (e.g., run, walk, bike). We show that, when compared with standard Spark Streaming, the addition of privacy comes at the cost of doubling the execution time.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.